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The IUD is a safe and reversible method, which requires little effort on the part of the user once 
inserted and offers 10 years of protection against pregnancy.  In spite of these advantages, the use 
of the IUD in relation to other contraceptive methods is reported to have either stagnated or 
declined in a number of countries including Ghana.  Given the lack of understanding of the 
reasons why IUD use in Ghana has stagnated and may well have declined, this study addressed 




What client characteristics affect the demand for and use of the IUD? 
What are the provider and system characteristics that shape use of the IUD? 
What can be done to reduce barriers to the use of the IUD? 
The overall aim of the study was to inform the Ghana Health Service, USAID and other partners 
on future directions for contraceptive promotion and supply.   
The study was descriptive involving both quantitative and qualitative methods of data collection. 
The study covered a period of nine months, March – November 2002.  The first part of the study 
was a secondary analysis of data from the Ghana Demographic and Health Survey (GDHS) 
1988,1993 and 1998, Ghana Situation Analysis (GSA) and existing service statistics, to explore 
trends in the use of the IUD.  The second component of the study collected qualitative data using 
a combination of in-depth interviews, focus group discussions (FGD) and simulated client (SC) 
surveys in three regions, namely Greater Accra, Eastern and Volta. These regions were selected 
on the basis of trends (increasing, decreasing and non-use) in the proportion of married women 
currently using contraceptives that are using the IUD.   
Over the period 1988 - 1998, knowledge about the IUD has been relatively high. However, a very 
low percentage of women contraceptive users report ever using the IUD.  Similarly, data on 
current use during the survey (GDHS) period shows stagnation of the IUD compared to other 
methods. Reasons for discontinuation of use varied by contraceptive method.  Overall, side 
effects were cited as the major reason for discontinuing the IUD compared to other methods.   
The stagnating demand for the IUD as a family planning method can be attributed to several 
factors, including perceptions and rumours about the method.  The design of the IUD and fear of 
weight loss associated with its use also discourages potential acceptors. Other barriers impeding 
IUD use are insufficient promotion of the product (i.e. poor demand creation) and insufficient 
number of providers with practical experience.  
Contrary to the general belief that providers’ bias against the product may contribute to the 
decline in use of the IUD, the findings show that in general, providers have a favourable attitude 
towards the product. 
 
 










Marketing of the IUD should be intensified through the Ghana Life Choices Program, 
using multiple strategies including branding of the product, and the testimonies of 
satisfied clients to dispel rumours and demystify the product; 
There is a need for IUD-focused training and for the creation of a critical mass of trained 
IUD providers; 
The MOH should review the National Reproductive Health Service Protocols on who 
qualifies to insert the IUD, and also to clarify the eligibility criteria with regard to 
nulliparous and HIV infected clients; 
There is a need to address issues related to cost.  Clients should be informed about the 
ease and cost effectiveness of using the IUD; that it is a one-visit only method (plus 
check-up) in contrast with injections or pill that require routine visits. 
 
 







The IUD is a safe and reversible method, which requires little effort on the part of the user once 
inserted and offers 10 years of protection against pregnancy.  In spite of these advantages, family 
planning clients can be reluctant to use the IUD and health workers can be reluctant to provide it.   
In a number of countries, including Ghana, the use of the IUD in relation to other contraceptive 
methods is reported to have either stagnated or declined (e.g. Costello 1998; GDHS 1998).  For 
instance, the use of the IUD among married women declined in Indonesia from 13 percent in 
1991 to 10 percent in 1994 (Hoesni et al. 1995).  In Kenya, IUD use dropped from 31 percent 
among modern method users in 1984 to 15 percent in 1993 (Stanback et al. 1995).  In Guatemala, 
IUD use has remained stable at around 2 percent despite an overall increase in contraceptive 
prevalence from 23 percent in 1987 to 38 percent among women in union in 1998/99 (Brambila 
2001).  In Ghana, national estimates from the Ghana Demographic Health Survey  (GDHS) 
indicate that modern contraceptive prevalence doubled from 5 percent in 1988 to 10 percent in 
1993, and increased to 13 percent in 1998.  A steady increase in the use of the pill, injectables 
and condoms has been observed.  However, use of the IUD has remained stagnant at one percent 
over a period of 10 years (GDHS 1998). 
Overall, couples’ knowledge of family planning methods is high (89%) in Ghana, but varies by 
type of method.  Only 35.5 percent of the couples had ever heard about the IUD (1998 GDHS). 
The IUD is readily available through the Ghana Health Service (GHS), Ghana Social Marketing 
Foundation (GSMF), Ghana Registered Midwives Association (GRMA), and Planned 
Parenthood Association of Ghana (PPAG) clinics.  However, recent service statistics drawn from 
these sources show a 40 percent decline in the provision of the IUD from 25,000 acceptors in 
1995 to only 10,000 in 2000.  Yet the Ghana Situation Analysis study shows convincingly that 
the IUD, and its insertion equipment, are available at most family planning service delivery 
points (Ghana Statistical Service 1997).  Also, information exchange on the IUD takes place in 
almost three-quarters of provider-client interactions, and yet this does not seem to translate into 
increased demand for the method (Ghana Statistical Service 1997).  Country specific reasons for 
the stagnating or declining use of the IUD are still unclear. 
A study among IUD acceptors in Indonesia points out that changes in the use of the IUD over 
time have been caused by a variety of factors including availability of methods, availability of 
medical facilities and skilled personnel, campaigns to promote specific methods, medical 
barriers, side effects, management of side effects and changes in user preferences (Hoesni et al. 
1995).  With respect to side effects and health concerns, some studies show that use of the IUD is 
significantly associated with Reproductive Tract Infections (Bhatia and Cleland 1995).  Indeed, 
the World Health Organization’s (WHO) medical eligibility criteria for safe use of contraceptives 
state that current sexually transmitted infection (STI) contraindicates IUD use, as does any 
previous STI that has not been cured for at least three months (World Health Organization 1996).  
The guidelines also emphasize that insertion of the IUD in an HIV- infected woman or one who 
is at high risk of infection is not usually recommended. 
Safety concerns for HIV-positive women using IUDs include the fear that a woman’s immune 
system may be weakened and unable to fight off infections, such as another STI that could lead to 






pelvic inflammatory disease (PID).  Findings from a recent study in Kenya, however, raised 
questions about the WHO guidelines. The study found that 156 HIV-infected women, including 
those whose immune systems were suppressed at the time of the IUD insertion, had no more 
overall complications (i.e. PID, removal due to pain, bleeding or pain, expulsion or pregnancy) 
following insertion than did the 493 uninfected women (Sinei et al 1998). 
Regardless of such findings, in certain settings these guidelines seem to have decreased demand 
for the IUD as well as brought about discontinuation among existing acceptors.  In the 
Philippines, side effects and/or health concerns were the most commonly cited reason for 
discontinuing use of the IUD.  Program statistics show that 22 percent of IUD users discontinued 
use within a year of adoption because of side effects and health concerns (Costello 1998). A 
study in Kenya identified five interrelated factors for the declining trend in the use of the IUD: 
fear of HIV acquisition/transmission, poor quality of care, poor product image, and provider bias 
or preference, and changing client method preferences (Stanback et al 1995). 
At the program level, the critical question for understanding the determinants of contraceptive 
method choice is whether use of a method is predominantly provider or client driven (Stanback et 
al 1995; Magadi et al 2001).   Provider driven practices include the provider favouring some 
methods and discouraging others in the absence of sound medical rationale, as well as failing to 
ascertain and consider the preferences of the client (Speizer et al 1998).  In an on-going study to 
assess the declining use of the IUD in Guatemala, Brambila (2001) argues that such problems 
possibly originate from the lack of IUD training among service providers, who may not feel 
confident to offer the service to potentially interested women, or, based on personal experiences, 
providers might have personal preferences.  Providers might simply have a generalized negative 
feeling towards the IUD. On the other hand, method choice is also substantially affected by client 
or individual’s fears of health side effects, whether these are real or based on unfounded rumours 
(Ngom 1994; Rutenberg & Watkins 1997). 
Given the lack of understanding of the reasons why IUD use in Ghana has stagnated and may 






What client characteristics affect the demand for and use of the IUD? 
What are the provider and system characteristics that shape use of the IUD? 
What can be done to reduce barriers to the use of the IUD? 
Study Objectives 
The overall aim of the study was to inform the Ghana Health Service, USAID and other partners 
on future directions for contraceptive promotion and supply.   
The immediate objectives included: 
To examine the determinants and switching pattern/behaviour of IUD users; 
To assess the role of socio-cultural perceptions and misperceptions on the use of the IUD; 










To assess providers’ and clients’ attitudes towards the use of the IUD; 
To assess the content and quality of information exchange between the provider and client 
on the IUD; 
To identify provider and other system barriers including pre-service and in-service 
training, logistics, supply and cost issues that may restrict clients’ access to the IUD; and 
To identify policy and program implications for the revitalization, if necessary, of IUD 
use in Ghana. 
Research Methodology 
This was an in-depth assessment involving both quantitative and qualitative methods of data 
collection. The first part of the study was a secondary analysis of data from the GDHS, and 
existing service statistics, to explore trends in the use of the IUD.  The second component of the 
study involved the collection of qualitative data through in-depth interviews, focus group 
discussions and the use of simulated clients. 
Sampling 
The ten regions in the country were first grouped according to the patterns of IUD use (Table 1).  
Three regions (Greater Accra, Eastern and Volta) were selected on the basis of trends (increasing, 
decreasing and non-use) in the proportion of married women currently using contraceptives that 
are using the IUD. 
 
Table 1: Patterns of IUD use 
IUD Use Regional trends of 
IUD Use 
CPR 









































































Secondly, the region with the highest contraceptive prevalence level was purposively selected to 
maximize familiarity with the method, but also to understand factors that shape the fluctuation in 
the use patterns of the IUD particularly in the case of the Greater Accra Region.  The study sites 
are summarized in Table 2. 
 




(N = 6) 
Sub-district 
(N = 12) 
Public facility 
(N = 17) 
Private facility 
(N = 6) 
1. Accra metro 1. Kpeshie 
2. Okai Koi 
La Polyclinic  
Kaneshie Polyclinic 
Achimota Hospital 












Alpha Clinic (Madina) 
3. New Juaben 5. Koforidua     
Municipal 
6. Oyoko 
Central Hospital MCH  
Oyoko Health Post 
Koforidua Clinic  




4. Suhum 7. Suhum 
 
8. Asuboi 
Suhum Dist. Hospital 
Suhum MCH  
Asuboi HC 
None 










6. Hohoe 11. Akpafu 
 
12. Gbledi 
Hohoe District Hospital 






Two districts (rural and urban) were randomly selected from each region, and then two sub-
districts were randomly selected from each district, giving a total of 12 sub-districts.  One 
government health facility in each sub-district and the district hospitals were included in the 
study.  In addition, two private facilities were randomly selected from each region.   
 
At least one family planning service provider from each of the selected service delivery points 
(SDP) was randomly selected and interviewed. A total of 35 providers were interviewed.  The 
majority of the providers interviewed were midwives (26), with a few community health nurses 
(5) and medical officers (2). 















o Policy Project 
o Prime/Intrah 





o Midwifery School,  
o Public Health Nursing  
      School 
Government 
Agencies 
o Reproductive and Child 
      Health Unit, GHS  
o National Population  
      Council 
Data Collection Methods 
In-depth interviews 
In-depth interviews were conducted at both 
the national and regional levels, with the aim 
of exploring contextual and programmatic 
factors expected to influence provision of 
the IUD.  At the national level, in-depth 
interviews were held with senior policy 
makers in the Reproductive and Child 
Health Unit of the Ghana Health Service and 
the National Population Council (NPC).  
Key staff at IUD distributing sources in the 
country, IUD insertion training institutions, 
and USAID Collaborating Agencies were 
interviewed. 
 
Focus group discussions 
Focus group discussions (FGDs) were held in all three study regions to examine contraceptive 
choice determinants among potential family planning clients.   
The IUD is a method that is normally recommended for spacing or limiting the number of 
pregnancies.  Thus, in order to understand the demand factors for the IUD, the group discussions 




Women who are interested in having additional children but want to space them  
Women who want to stop having children 
Actual users to obtain their perspectives about the method.  
However, the intended group discussion with actual users had to be cancelled due to difficulties 
in recruiting participants.  Altogether, 12 group discussions were held in 6 urban and 6 rural 
communities in the three Regions. The communities were randomly selected from the catchment 
area of the facilities visited. The group participants were recruited from either the family planning 
clinics or the maternal and child health care clinics of the respective SDP.  The participants of the 
focus group discussions were women aged 18-48 years who had at least one child. They were 
mostly Christians and had primary level education. All participants had lived in their 
communities for at least four years.   
Simulated clients 
Simulated clients  (SC) were used to examine the provider knowledge and attitudes regarding the 
IUD and whether providers recommend the IUD to women who intend to delay, space or stop 
giving birth (see Huntington et al 1993).  This component also investigated possible provider 
biases related to age, parity, and marital status (including type of marriage). The use of the SC 
method originates from a need to remain as unobtrusive as possible.  Concurrence to undertake 






the study was sought from the Regional Directors of Health Services in the respective study 
regions.   
 
The SCs were trained to assume specific roles during their visits.  They were either adolescents or 
adult women who needed information about the most effective method for delaying, spacing or 
stopping birth. They were to request a contraceptive method they could use for a long time (at 
least two years), inform the provider that they are in a stable relationship and that, to the best of 
their knowledge, they had no sexually transmitted diseases.  Since pregnancy contraindicates 
most methods, the SC was asked to tell the provider that she was in the fourth day of 
menstruation.   The SC was instructed to specifically ask about the IUD if the provider did not 
volunteer information about it, to ensure that some information was exchanged about the method 
in each interaction.  The profiles for the SCs are summarized in Table 4. 
 
Table 4:  Simulated Clients profile 
Clients Client Profile 
Adolescent woman 1. Married nulliparous, interested in delaying first 
birth 
2. Unmarried nulliparous, interested in delaying 
birth 
3. Married with at least one child, interested in 
spacing 
Adult woman 4. Married with at least one child, interested in 
spacing 
5. In polygamous marriage, interested in spacing 
6. Unmarried, interested in spacing 
7. Multiparous, interested in stopping 
 
Seven individuals, who represented each of these profiles, were recruited and trained.  Each made 
one visit to the 23 selected SPDs using the same scenario for each visit. A total of 159 SC visit 
were made. The visits were undertaken on separate days to minimize suspicion and/or potential 
bias.   
 
The SCs were trained on the basis of a standardized scenario to ensure that they all could 
convincingly and accurately present it.  They declined a pelvic exam, and when consultation 
progressed to the point of inserting the IUD, the SC indicated that she wanted to consult with her 
partner first, thanked the provider and left.  A de-briefing interview was held between the SC and 
the Team Leader immediately after the clinic visit.  The SC together with the team leader then 




Data from the in-depth interviews with program managers and focus group discussions were 
transcribed from audiotapes by the interviewers. The research team then analyzed the transcripts, 






categorized responses by themes and wrote summaries. Data from the SCs visits and the provider 
interviews were coded, cleaned, entered and analyzed at the HRU using Epi Info data entry and 
analysis software. 







Trends in IUD use  
The analysis (see Table 5) shows that over the 
period 1988 - 1998, women’s knowledge 
about the IUD has been increasing, although 
it is relatively low in comparison to other 
modern methods. A very low proportion of 
women contraceptive users report ever using 
the IUD.  Similarly, data on current use 
among all women shows a steady decline in 
the use of the IUD. Whereas the pill, injection 
and condoms have gained usage over the 
years, IUD use dropped from 4.0 percent in 
1988 to 2.8 percent in 1998; illustrating a 
decline over a period of 11 years. This trend 
also applies to female sterilization.   
Data on preferred method for non-users is 
included in Table 6 below.  Here again, a low 
preference for the IUD over the period (1988, 
1993, 1998) is shown. The future method of 
choice for non-users seems to be the 
injection, followed by the pill.  There is also 
an intended preference for both the condom 
and Norplant.  
Table 6: Percentage of preferred method 
for non-users of FP 
Year 1998 1993 1988 
N 1,872 1,855 1,334
Pills 19.6 21.9 23.4 
IUD 2.4 2.9 2.5 
Injection 36.1 28.5 19.1 
Norplant 2.62 0.70 - 
Diaphragm 0.9 2.3 1.5 
Condom 6.3 5.9 1.1 
Female 
Sterilization 
2.6 3.0 8.9 
Male Sterilization 0.0 0.1 0.1 
Periodic 
Abstinence 
7.4 7.4 8.4 
Withdrawal 0.5 0.9 0.5 
Foaming Tablet 2.6 0.7 0 
Other 6.1 0.7 5.3 
Don’t know 0.4 0.0 1.8 
Knowledge of Method 1998 1993 1988 
N (All women) 4,843 4,562 4,488
Any modern method 92.5 90.6 73.8 
Condom 86.8 79.5 48.5 
Pills 78.4 79.4 59.7 
Injection 77.6 74.8 42.6 
Female sterilization 65.4 67.3 54.1 
Periodic abstinence 59.4 57.1 39.0 
Withdrawal 54.5 52.3 31.0 
IUD 49.3 44.5 36.7 
Diaphragm 42.0 53.5 36.6 
Male sterilization 26.3 21.4 10.7 
Implant 21.2 4.4 - 
Ever used a method 1998 1993 1988 








Withdrawal 15.0 2.6 7.8 
Pill 14.9 15.1 12.8 
Condom 14.2 13.0 4.5 
Injection 5.8 3.7 0.9 
Diaphragm 5.1 8.8 7.9 
LAM 3.4 - - 
IUD 1.9 2.2 1.2 
Female sterilization 0.9 0.8 0.8 
Implant 0.2 0.0 - 
Male sterilization 0.0 0.0 0.0 
Others 1.3 0.0 2.7 
Current users 1998 1993 1988 
All women using 872 862 552 
Periodic abstinence 31.6 38.6 49.6 
Pill 17.2 14.8 13.0 
Condom 15.6 13.8 2.4 
Injectable 12.3 6.4 1.6 
Withdrawal 7.2 10.1 6.5 
Female sterilization 5.1 4.1 7.3 
Diaphragm/Jelly/Foam 3.9 5.8 9.8 
IUD 2.8 3.7 4.0 
Other methods 2.2 2.7 4.9 
LAM 1.7 - - 
Implant 0.5 0.0 - 
Male sterilization 0.0 - - 
Table 5: Summary findings of secondary 
analysis of GDHS: 1988, 1993, 1998 (%) 







The 1993 GDHS covers a question on reasons for discontinuing a method.  Overall, side effects 
were cited as the major reason for discontinuing use of the IUD.  Among the 17 IUD users 
interviewed, nine had stopped use because of side effects.  Other reasons given were desire for 
more children (4), religion (1), health concerns (1), infrequent sex (1), and not married (1). 
 
Annual family planning records show a steady increase in the acceptance rates of the injectable at 
service delivery points and a declining trend for all other methods including the IUD (see Table 
7). 
 









Method 1995 1996 1997 1998 1999 2000 2001 
IUD 3.3 4.5 2.9 3.8 3 2.4 1.9 
Combined Pill 30 27 32 24.9 20 20.3 23.3 
Mini Pill 2.6 3.9 2.3 2.1 3 2.3 2 
Male Condom 20 15.3 12.6 9.5 12 13.4 11.1 
Female Condom - - - - - - 1.2 
Injectable 28 41.5 41.3 52.3 54 54.3 54.7 
Foaming Tablets 10 7 8.0 6 6 5.5 4.1 
Female Sterilization <1 <1 <1 0.5 0.6 0.2 0.2 
Implant - 0.2 0.2 0.2 0.7 1.0 1.0 
Male Sterilization - - - - - 0.4 - 
Natural <1 0.1 0.3 0.7 0.3 0.2 0.1 
Source:  Annual Reports, Reproductive & Child Health Unit, Ghana Health Service 
Note: Available acceptors data is incomplete Therefore columns do not add up to100%
Knowledge, Perceptions and Practices 
Knowledge about the IUD 
The responses given by the various FGDs were quite similar. All participants had heard about 
family planning and could mention a few methods. The most frequently and spontaneously 
mentioned method was the injectable, followed by the pill and sometimes Norplant. The IUD was 
mentioned occasionally and usually required some prompting by the facilitators. Many of the 
participants had never seen the IUD, though they had heard about it. Those who had seen it said 
they saw it during ‘weighing’ at the Reproductive and Child Health (RCH) clinics. They 
described it as a metal thing or spring with strings attached to it. As one respondent stated: “It is 
like the hook they use to catch small fish.”  Others described it as ‘a cross’ and ‘a needle.’  One 
participant mentioned that the IUD is an object inserted at the entrance of the womb to prevent 
the entry of sperm. 






Fears and Rumours about the IUD 
Most of the FGD participants had not ever used or 
seen the IUD. When shown a sample, they expressed 
some apprehension about how such an object could 
be inserted into one’s body. Their responses 
repeatedly underlined their fears (see Box 1). 






“I am afraid because of the 
design.” 
“The metal in the middle is scary.” 
“It can hurt you.” 
“It is like a broom, it can hurt you 
during sex.” 
“It is a wire, maybe it will rust and 
destroy you…I think that is the 
cause of the bleeding.” 
 
They speculated about the possible effects. They 
wondered whether such a thing would not destroy a 
man’s genitals, cause sickness, slip inside one’s body 
if not properly inserted, melt in the body, or irritate 
the partner’s penis. The presence of the strings was 
also a cause for worry; as stated by one respondent:  
“I hate the strings.” 
 
Discussants worried about whether their husbands would not accidentally pull the strings during 
intercourse. The possibility that it could cause some discomfort for their spouses was mentioned 
frequently. Some respondents also said it could get pushed into the stomach by a long penis. 
Others felt the presence of the strings would make their partners suspect that they were up to 
something, specifically “Juju” - love medicine.   As noted by one respondent: “As for the men, 
they are troublesome.  Before you realize he has seen it, and will say you have done juju.” 
Another added: “Indeed he will think it is medicine to make him love me more.” 
 
Discussions with providers also confirmed that clients present them with these fears.  In their 
view, clients have many misconceptions about the IUD and its side effects. Clients believe that 
the IUD causes marital disharmony, abortion, that it can fail, and that it causes heavy bleeding, 
loss of weight and even death. 
 
The study revealed several rumours surrounding the IUD. FGD participants mentioned that they 
had heard several things about the IUD.  A participant narrated a story about a friend whose 
husband deserted her because he thought the IUD strings felt like a snake. The most frequently 
expressed rumour was that the IUD causes severe bleeding leading to excessive weight loss and 
ugliness, unlike the injectable which makes one bleed less, and therefore leads to weight gain and 
beauty. Instances were cited where friends who had used IUDs felt dizzy and collapsed. There 
was even one death cited. Other rumours stated are highlighted in Box 2. Simulated clients 
mentioned that providers were aware of these rumours and made attempts to dispel them during 
interaction without being prompted. 
 

















Can cause heart disease or heart attack 
Can lead to abdominal distension – one person even thought the IUD in causing 
abdominal distension can then cause fibroids …“Is this not the same rubber which 
gives fibroids? Because the way the rubber makes your abdomen big...I hear 
fibroid also makes your abdomen big.” 
Can cause infertility 
Causes offensive discharge 
Can cause disease 
Can cause irritation of the genital area 
Can lead to painful intercourse 
Can shift (become displaced), resulting in pregnancy 
Can fail and one can get pregnant even with the IUD in place. In such instances 
the baby may be born with it 




Advantages of the IUD 
A few FGD participants that had heard or seen the IUD echoed some positive attributes to the 
method.  They stressed that the IUD is effective and easily reversible (more effective than the pill 
because one could forget to take it), and they had used it before and there was no reason for 
alarm. 
 
Providers themselves generally view the IUD positively in the sense that it is the most cost-
effective of all methods; it is convenient and non-hormonal with less systemic side effects. 
 
Almost all trainers, policy makers and program managers interviewed were of the opinion that 
the IUD is a useful family planning method. One program manager stated: “The IUD has a major 
role to play because it is a bridge between the permanent methods and the hormonal.”  She 
explained that because one can have it for many years without any problems, if one is unable to 
make the decision for permanent method they could use the IUD. 
 
Eligibility criteria 
The 1999 Ghana National Reproductive Health Services Protocol (NRHSP) outlines the 
eligibility and non-eligibility criteria for the different family planning methods and also gives 
instructions to be followed by the service provider (see Box 3).  The eligibility and non-eligibility 
criteria for use of the IUD state that: 
 
 All women are eligible for the IUD (Copper T); however, it is not the first choice method 
for nulliparous women, particularly adolescents. 








Pregnant women, women with unexplained vaginal bleeding (before evaluation), cancer 
or reproductive tract infections, or reported allergy to copper are absolutely ineligible for 
the IUD. 
Women with past history of ectopic pregnancy, increased risk of STIs including multiple 
sexual partners, complete expulsion of hydatidiform mole, anaemia, uterine fibroids, 
valvular heart disease and those that are HIV-positive are to be considered relatively non-
eligible for the IUD.  
 
The NRHSP also emphasizes that the IUD is not the first choice method for HIV-positive 
women, and that the condom should be added to all methods.   













It is advisable not to insert an IUD until six to eight weeks postpartum, unless the provider has been 
trained for post partum insertion; 
Client can have an IUD inserted if there is: no heavy bleeding and no sign of infection upon pelvic 
examination; 
If the client is not pregnant, the IUD may be inserted at any time during the menstrual cycle.  If the 
provider is unsure of pregnancy, but has no pregnancy testing option, give a barrier method and re-
examine four week later; 
If the client has had severe or repeated pelvic infections, treat client and partner(s), as appropriate. 
If client desires more children, do not insert an IUD.  Help the client make an informed choice of 
another effective contraceptive method; 
Over the past three months, if the client has had any abnormally heavy periods, bleeding between 
periods or after intercourse, the provider should evaluate client by history and during pelvic exam 
and refer, as appropriate; 
If the client considers her bleeding during periods to be unusually heavy or often experiences severe 
menstrual pains, the provider should encourage the client to make an informed choice of another 
effective method; 
If the client or her partner has other sex partner(s) outside the relationship, in addition to the IUD the 
provider should encourage the client to use condoms to protect her against STI/HIV/AIDS; 
If the client is at risk of STI, the provider should help the client to make an informed choice of 
another effective method(s) which also protects against STI; 
If the client has ever had an ectopic pregnancy, the provider should counsel the client to use a 
combined oral contraceptive every day.  If the client cannot or will not consistently use COC or 
another reliable method, high dose progestin-releasing and copper IUD provide 50 percent 
protection against ectopic pregnancy and are safe to use; 
If the client has severe anaemia on general examination, counsel and consider another method 
If the client has any ulcers and sores, treat or refer.  Do not insert an IUD until all genital infections 
are cured.  Encourage use of condoms and/or spermicides to protect against STI/HIV/AIDS; and 
If the client has an inflamed vaginal wall and a discharge in the vagina, treat and refer.  Do not insert 
until an IUD until all genital infections are cured.  Help the client choose another method. 
 
Source:  MOH 1999 National Reproductive Health Service Protocols.  Republic of Ghana, Ministry of 
Health January 1999 
 
 






When asked about which category of women are eligible for the IUD, most providers said they 
would give the IUD only to women who have delivered before and to faithfully married couples 
or clients with single partners. Other categories of clients mentioned included women with 
normal menstrual flow, those who want long-term contraception but not sterilization, any woman 
who chooses the IUD, and women who want to stop child bearing.  Most providers frequently 
mentioned the category of nulliparous women as non-eligible.  Certainly, some of the providers’ 
views are the opposite of what the NRHSP recommend.  Table 8 compares the providers’ views 
and the NRHSP eligibility and non-eligibility criteria.  
 
Table 8: A Comparison of NRHSP on eligibility for the IUD and providers’ views 
 
National RH Service Protocol 
eligibility & non-eligibility 
criteria 
Providers’ views Providers’ reasons for 
non-eligibility 
All women are eligible for the IUD 
(Copper T), but for nulliparous 
women, particularly adolescents, 
the IUD is not the first choice. 
All women are eligible for the IUD, 
except adolescents who are 
nulliparous. 
Depth of uterus would 
not be wide for insertion
Possibility of causing 
infertility 
Women with pregnancy, 
unexplained vaginal bleeding 
(before evaluation), cancer of the 
reproductive tract infections, or 
allergy to copper are absolutely 
non-eligible for the IUD. 
Women who are allergic to 
copper are ineligible for the IUD.  
Reaction to copper 
Women with a past history of 
ectopic pregnancy, increased risk 
of STIs including multiple sexual 
partners, complete expulsion of 
hydatidiform mole, anaemia, 
uterine fibroids, valvular heart 
disease and those that are HIV- 
positive are relatively non-eligible 
for the IUD. 
Women with multiple sexual 
partners are non-eligible for the 
IUD. 
Women with complications such 
as fibroids, history of ectopic 
pregnancy and previous 
caesarean section are non-
eligible for the IUD. 
Women with untreated vaginal 
discharges, and STI/HIV are non-
eligible for the IUD. 
Spread of infection 
 
 
Sounding of the uterus 
will not be possible and 
perforation can occur 
during insertion 
 
Spread of infection 
 
When asked about the timing for IUD insertion all providers said they would insert the IUD when 
clients were in their menses for ease of insertion and exclusion of pregnancy. This finding was 
confirmed during simulated client interactions with providers. They were advised to return during 
menses for insertion. 
 
It was common for providers to discourage the use of the IUD by nulliparous clients.  In 22 of the 
46 interactions where a nulliparous profile were presented, simulated clients were told they could 
not use the IUD.  However, in almost all simulated interactions, clients did not have to ask the 
providers about the IUD, providers spontaneously discussed and explained about it.   Reasons 
given for refusal included fear of attributing possible future infertility to IUD use and an 






assumption that nulliparous women have multiple partners and therefore are more likely to be at 
risk of infections. The IUD was also discouraged in three interactions involving older simulated 
clients because they were more than 35 years old and wanted to space child bearing.  In one 
instance the simulated client was told, “You are already 35 and you want to space but the IUD is 
for 10 years; by the time you remove it you will be in your menopause.”  For this reason, a short-
term method (i.e. the pill) was recommended. 
 
The majority of providers interviewed said they would recommend the IUD to their friends 
because it is non-hormonal, users have menses every month, and it is a safe and reversible long-
term method.  A few providers who stated that they would not recommend the IUD to a friend 
expressed concerns about heavy and prolonged bleeding which can lead to death.  About half of 
the providers said they would use the IUD themselves. Those who would not use it cited reasons 
such as having unfaithful partners, preference for natural family planning and ineffectiveness of 
the IUD. 
Information exchange with simulated clients 
Simulated client visits revealed that providers mentioned a range of methods during all 
interactions.  The IUD was mentioned in almost all interactions (147/159) and spontaneously 
mentioned in 123 of these instances.  In 30 of the interactions, the SCs felt that providers had 
over-emphasized some methods, particularly the pill, condom, injection and Norplant.  This 
practice was common in interactions that presented a nulliparous profile.  Permanent methods 
were rarely mentioned.   
 
Contraceptive samples were used as a visual aid in over half of all the interactions.  The IUD 
sample was given to simulated clients in 87 of 159 interactions.  Flip charts and pamphlets were 
used in one-third of the interactions.  Sketches, questionnaire cards and improvised models were 
also sometimes used. 
 
Providers nearly always asked the simulated client about their method preference (133/159).  And 
when the SCs expressed interest in the IUD, the providers’ responses varied.  In 87 of 159 
interactions the providers said it was okay and in 28 of 159 the providers did not like the method 
choice. 
 
Providers discussed the long-term use of the IUD; most providers stated that the IUD could be 
used for a period of 10 years.  In 12/159 interactions duration of use was not mentioned at all.  
However, several of the providers did not mention that the IUD is an easily reversible method. 
 
Advantages of the IUD were mentioned in 61 percent (97/159) of the instances.  The frequently 
mentioned advantages include long-term (90), effective (60), easy to use (59), and quick return to 
fertility (61).  The providers also mentioned that the IUD does not “mix with blood.” 
 
Disadvantages were mentioned in 88 of the interactions.  The commonly mentioned ones include 
irregular or heavy menstrual bleeding, abdominal cramping, and pain during insertion and 
removal.  None of the interactions included a discussion on STI/HIV. 
 






Dual protection and concerns about transmission of STI/HIV 
Almost all the participants in the FGDs had heard of STIs. The most frequently mentioned were 
HIV and gonorrhoea, and occasionally syphilis. Regarding their opinion on whether the IUD 
could protect against STIs, participants said they were aware the IUD does not protect against 
these diseases.  A few respondents had the misconception 
that the injectable would protect against diseases as well 
(Box 4), but many felt the condom offered the best 
protection.  
Box 4: Injection prevents disease 
“The nurses said the injection can 
protect us from syphilis but not AIDS.” 
 
 “The loop can give diseases but the 
injection protects us against diseases.”
 
 
They had knowledge of both the male and female 
condom. Participants in one group cited a particular 
chemical store where both female and male condoms had 
been packaged as a set for 2000 cedis  (US$ 0.251), which 
they thought was quite affordable.   
 
All providers said they would treat the STI before giving the IUD. When asked whether they 
would recommend the IUD to an HIV-positive client, all except one provider would not give the 
IUD.  Instead they would counsel the client and recommend another method. 
 
When asked what they worried most about during insertion of the IUD, most providers expressed 
fear about perforation of the client’s uterus (24/35) as compared to concerns about infecting 
themselves or the client (6/35). When asked specifically about fear of being infected with HIV 
during insertion, about a third said they were concerned because the gloves could not be trusted; 
the disease is infectious and has no cure. Those who did not worry said they used sterile gloves 
and proper decontamination procedures. 
 
Contrary to this opinion some program 
managers and trainers mentioned that providers 
were not giving the service mainly because of 
the fear of personal infection with HIV (Box 5).   
 
Method preference 
Regarding their opinion about shifting 
preferences, participants mentioned that they were not aware of this observation. They however 
suggested that the many side effects and rumours as well as fear of the method (product) could 
partly explain the observed shifting preferences. Participants also said that the fact that the IUD 
does not protect one from STI could be a possible reason for preference of other methods (see 
Box 6). 
Box 5: Program Manager View 
“A lot of the staff are afraid of inserting the IUD 
because of the HIV/AIDS…Since they are not 
very sure of the infection prevention measures 
available, they don’t want to go into the pelvis of 
the woman, and therefore discourage the women 
from accepting that method as they don’t want to 
contaminate themselves.” 
 
A little over half of the providers were of the 
opinion that clients were switching from the IUD to 
other methods. Reasons cited include infections, 
misconceptions and the desire to try out new 
An Assessment of Trends in IUD Use in Ghana     17 
 
 
Box 6: Preference for other methods 
“The condom is easy to use, you just get up 
and wear it. On the other hand the advent of 
AIDS makes wearing the IUD difficult since it 
only prevents pregnancy and not diseases 
thus one needs a condom in addition. This 
will make it double and more expensive.”                                                  




methods such as Norplant. In comparison to other long-term methods such as the implants and 
the injectable, providers said that the IUD rarely featured as a first choice method among clients 
seeking long-term methods. 
 
Most program managers and trainers were of the opinion that IUD use had slowed down 





Poor image and misconceptions about the product. They suggested that there has been limited 
effort at dispelling rumours, and promoting the method through advertisements as is done for 
other products.  
 
“My opinion really is that it has not been given the publicity it deserves.” 
 
“You see these adverts also have a lot of impact. Injectables have been well 
advertised so that could be the reason.” 
 
“I think there is a shift from IUD towards the injectables and so the acceptor rate is 
falling. We haven’t really done any study to find out but probably clients are shifting 
to other methods which maybe they find safe. There are still these myths and 
mysteries about IUDs and I think they spread it from community to community and 
maybe the midwives are not also doing much to encourage users.” 
 
Risk of infection to both clients and providers, with specific reference to HIV:  
 
 “I think if they don’t do something about the infection prevention measures the staff 
will not have the confidence to do it and if the staff don’t have the confidence to do it 
they are not going to encourage the people.” 
 
“We do know that many sexually active people do not have single partners, and 
because of the risk of infection many people do not want to use the IUD. Particularly 
with the onset of HIV, many people want to protect themselves and perhaps the way 
to go may be the use of condoms and that may contribute to the decline in the use of 
the IUD.” 
 
“I have problems because our women tend to have infections too much. The midwives 
tell you that maybe if you have 10 deliveries as much as 8 of them will be discharging 
(referring to vaginal discharge)… and people don’t seek help about these things, 
making them more susceptible to HIV.” 
 
Provider bias and ignorance. One program manager explained: 
 
“I think that a lot of us health workers are illiterates when it comes to family 
planning.  We don’t know much about family planning and therefore the information 
that we give to clients is nothing that we can talk about because a health worker can 
ask the client ‘do you want to die, why did you go in for IUD?’ Yes! People say it. 






Health workers! And when users have problems, health workers will tell them it’s 






Complexity of service provision. This has to do with the many requirements necessary for 
IUD insertion such as the need for sterilization equipment and pelvic examinations. Some of 
the interviewees had this to say: 
 
“You need the clinic setting which makes IUD insertion inconvenient in the field. 
Unlike the injectable, which does not require too much sterilization equipment.”  
 
“According to the National Policy and Standards, only midwives are trained to insert 
the IUD because of the need to sound the uterus.” 
 
The type of IUD available (only Copper T380A) was also suggested as responsible for 
declining use since it has been associated with abnormal discharge. As one respondent 
explained: 
 
“I strongly believe so because people had IUD insertion for more than 20-25 years 
when it was the Lippes and didn’t have much problem. But now it is not so.  I have 
heard a few people complaining about some peculiar discharges with the copper 
ones, but I haven’t seen any. Some service providers are saying that they think it is 
the IUD that is bringing about that type of discharge.” 
  
Training of service providers. A program manager said that, in her opinion, there appears to 
be a closer collaboration between the nurses and midwives trained for Norplant insertion 
because they are trained together as a team. With the IUD, however, collaboration between 
the public health nurse and midwives is sometimes poor because only midwives are trained. 
Furthermore the training methodology for Norplant, in their opinion, has contributed to its 
success.  
 
“The success with the implant has been that there has been training of midwives and 
nurses apart from doctors in insertion and removal, and that has increased access 
and the demand is being met more in those places.” 
 
Method preference: it was suggested that women do not like the IUD and even those who use 
it have shifted to other methods. 
 
“ The women themselves are rejecting it, so why do we want to force them?” 
 
“Anecdotally because we go through service providers, we have heard that Norplant 
for example is trying to take some of the IUD customers. Most of these customers 
opted for IUD because they didn’t like the hormone but then they also like the 
Norplant because they don’t have to go and see the service provider too often.  Again 
it does not have the associated infections and the heavy bleedings. This has to be 
backed scientifically of course.”   







Service Delivery System 
 
Training 
Although there are several institutions involved in family planning training, training in IUD 
insertion is limited to only a few institutions: the Ghana Registered Midwives Association 
(GRMA); the Public Health Nursing School (PHNS); Accra, and three Midwifery schools in 
Kumasi, Koforidua and Tamale.  GRMA has identified three facilities in the country as training 
centres for the IUD. The other institutions run a four-week comprehensive family planning 
course with emphasis on the IUD four times a year.  The course is sponsored by the UNFPA 
through the MOH/GHS. Table 9 shows the focus of training activities of the institutions. 
 
All 35 providers interviewed said they had had some sort of exposure to family planning training.  
However, only 7 of them had attended the four-week comprehensive Family Planning course that 
places emphasis on the IUD.  Out of the seven who had had the training, one had not done any 
insertions in the past year because of lack of demand for the method.  As explained by the 
provider: “The people here are not interested in IUD. They all prefer the injectable.  Their minds 
are already made up before they come to the clinic.” Fifteen out of thirty five providers 
interviewed had not done any insertions in the past year. Though a few said they do not need any 
training, many expressed the desire for refresher training to update their knowledge about the 
IUD. 
 
Table 9:  Family Planning Training Institutions in Ghana – Activities and Focus 














Safe motherhood for doctors & midwives Limited to counselling 




Pre-service midwifery training  







Pre-service midwifery training 
One month comprehensive FP course 
with emphasis on IUD* -- nurses & 
midwives 










Pre-service preventive health services – 
public health nurses 
One month comprehensive FP course 













(For private midwives) 
∗ This program is run at three institutions: Kumasi, Koforidua and Tamale. 







Supplies and equipment 
A 1997 Ghana Situation Analysis (GSA) study of the family planning covering 313 Service 
Delivery Points (SDP) across the country shows that only 56 percent of the SDP were able to 
offer the IUD.  Supplies were available at 91 percent of these SDP and only 11 percent reported 
stock-out during the last six months.  
 
In this study, none of the facilities in the Greater Accra region reported any shortage of the IUD 
or related expendables (gauze, disinfectant, gloves) in the past year. Out of the eight facilities 
visited in the Volta Region, only three offer IUD services and only one of these had had 
shortages in the past year.  The remaining five facilities do not provide IUD services because of 
the absence of trained personnel at four facilities and the religious inclinations of a provider at 
one facility.  In the Eastern Region all facilities visited provide IUD services and two had 
shortages in the past year.  The Copper T380A is the only type procured and distributed by the 
National FP programme. 
Cost 
Family planning services in Ghana are not free to clients. In view of this the MOH has 
standardized prices for the product. Pricing for related expendables is the responsibility of 
individual service delivery points.  Simulated clients reported that they were asked to pay 1000 – 
20,000 Cedis to have an IUD inserted in public facilities, with an average cost of 10,000 Cedis 
(about US$1.22). At the private facilities the fee ranged from 30,000 to as high as 200 000 Cedis. 
Policy 
According to the National Population Council (NPC) and the Ghana Health Service (GHS) the 
current national policy is that family planning methods should be made accessible and affordable 
to all. The policy also embraces the concept of quality of care and emphasizes giving information 
to individuals to enable them to make informed choices. The policy direction is for the public to 
have a wide range of choices with the public sector concentrating on long-term methods whilst 
the private sector deals with the short-term methods. However, in the context of STI/HIV and 
adolescent health needs, the actual practice is for both sectors (private and public) to promote 
condom use and dual protection.  
 
Regarding the IUD specifically, the GHS position from the interviews conducted is that it is a 
method that is well tolerated by many women, and that it is also long-term and cost effective. The 
risk of infection is not high for women in monogamous relationships, but it increases if the 
partner is unfaithful.  Thus, the GHS would not discourage the use of the IUD, but then dual 
protection has to be promoted as well.  One program manager interviewed, however, challenged 
this position:  
 
“I feel it’s very democratic to have a full range of methods if you can afford it, but if 
you have limited resources that should also influence your choice. So we have to look 
at how much that extra method is going to cost per intercourse and find out whether 
it is cost effective. So it depends on how much money you have but personally I think 
we can minimize the range...What is the trade off of IUD? Is it just because it is 
cheaper?” 







When FGD participants were asked the question “should the IUD be promoted as a family 
planning method?”  Most of them said that though they would not use it themselves, they would 
not mind it being recommended, as it may be useful for others.  
 
In response to the same question, program managers and 
providers proposed targeted information on the IUD 
through electronic media. They specifically mentioned 
‘emaa nkomo,’ a talk show program on issues affecting 
women.  They also proposed the intensification of public 
education using different strategies such as male 
involvement, the testimony of satisfied clients, and IEC materials such as leaflets and posters. 
Other actions recommended include training of untrained health personnel, introduction of 
postpartum IUD insertion, and ensuring availability of insertion kits. 
Box 7: IUD Useful to others 
 
“I do not like it but someone likes it, 
so when it is announced she will 
do it, but not me.” 
 
Program managers from two key social marketing agencies were asked whether they had specific 
activity shift towards or against any particular method.  Overall, the discussions revealed that 
none of these agencies had a deliberate activity shift towards or against any particular family 
planning method.  Rather both agencies had broad and practical shifts shaped by the nature of 
their activities.   
 
For instance, one social marketing agency has shifted from providing family planning to the 
general population to targeting youth with reproductive health services and therefore focuses on 
condom and pill services. Furthermore, Norplant and the injectable are considered convenient 
and cheaper to administer in the field because trained field assistants from mobile clinics provide 
them; this offers greater possibility of reaching more people than the IUD.   Program managers 
also admitted that they were limited in their efforts to promote the IUD in particular.  The IUD 
was also considered a difficult method to distribute in the community due to service 
complexities. 
 
Even so, one source from a distributing organisation was of the view that the IUD will always 
have a place on the Ghanaian market because it is an effective, long-term non-hormonal method, 
and there will always be clients who prefer it.  However they stated that there would be a 
continuous decline in its demand due to other competing products on the market. This 
competition, especially from Norplant, needs to be addressed.  Thus, the organization’s opinion is 
that until a survey is done to find out what the “hot buttons” for the IUD are, they are reluctant to 
go out and create a market for this product.  
 
Another major limitation mentioned was that the IUD, unlike other products, is unbranded, yet in 
social marketing the need to identify with “your” product is overriding.  Thus, it is considered 
difficult to disseminate information on the use of the IUD or even to carry out targeted market 
studies. For instance, condoms and injectables have been promoted because they are branded. As 
stated by one program manager, it then becomes “ours” and can therefore be easily monitored. 
Examples of such brand names mentioned include the “Famplan” and the “Champion” condom.  
 
 







The role of community perceptions on the use of the IUD 
 
These findings identify several community perceptions and misperceptions about the IUD that 
seem to contribute to its declining trends in Ghana. The perceptions, which were mostly negative, 
were mainly from potential clients.  Many of these clients, though, had never used or even seen 
the IUD, but had heard many rumours and speculation about it.  Rumours about the IUD 
therefore discourage its use and it is important that efforts are made to dispel them. The few 
respondents who had ever used the method had some positive things to say. Hence familiarity 
with the product may help remove some of the negative attitudes. 
 
The design of the product itself contributed to the negative image, inducing fear and 
apprehension in some women, as seen from the comments made by the focus group discussion 
participants.  The design gives credence to the speculation that it could cause harm to the body.  
 
The side effect of excessive bleeding and weight loss associated with use of the IUD is a real 
disincentive.   This may contribute significantly to the shifting client preferences away from the 
IUD to other methods such as the injectable, which coincidentally has the side effect of 
amenorrhoea and proven weight gain.   Information from the focus group discussions show that 
socially, weight loss is associated with unattractiveness and weight gain with beauty. This belief 
promotes the increased use of the injectable against the IUD.  There appears to be real 
competition from the injectable, which has the added advantage of having a preferred route of 
administration. The injectable is also popular because it is thought to be medicinal because of its 
mode of administration, and the fact that it gets into the blood circulation. On the contrary, the 
IUD does not “mix with the blood” as stated by a focus group participant. 
 
The concern expressed about the IUD irritating partners featured prominently and it justifies an 




Contrary to the general belief that providers’ bias against the IUD may contribute to the decline 
in use, these findings show that providers generally have a favourable attitude towards the IUD.  
They offer it as one of the options to clients and actually make the attempt to dispel associated 
rumours. Moreover, the assertion made by program managers/trainers that fear of contamination 
during IUD insertion could prevent the providers from recommending the method, is not correct.  
Providers’ fears had mainly to do with harm to the client during insertion, rather than to 
themselves.  This suggests that providers may not be confident of their insertion skills.  If indeed 
providers worry about having to conduct a vaginal examination before inserting the IUD, then 
what about other similar situations, such as delivery.  
 
Provider bias was found to be in relation to parity.  Providers admitted that they would not give 
the IUD to nulliparous women, including adolescents. This practice is contrary to the National 






Reproductive Health Protocols which state that: “The IUD (Copper T) is eligible for all women, 
but for nulliparous women particularly adolescents, the IUD is not the first choice.”  Thus, 
providers are not exactly acting within the guidelines, denying adolescents and nulliparous 
women access to a method that offers important advantages over other forms of contraception  -- 
it is non-hormonal and long-term, requires minimal compliance, and return to fertility is 
immediate.   
 
The NRHSP guidelines categorically stated that pregnancy is an absolute contraindication for 
IUD use. This may explain why providers insisted on excluding pregnancy in simulated clients 
before providing the method. 
 
The findings also show that providers give clients information about side effects of the method 
only if the client is eligible for it. No such information is given to non-eligible clients. According 
to the protocol, providers are expected to take a full history of the client before conducting a 
physical examination.  However, in practice it appears that providers do not take the full history 
before recommending or discouraging the use of a method.  
 
Considerations for dual protection 
 
According to the national reproductive health service protocols, the IUD is not a first choice for 
HIV-positive clients.  The use of the condom together with another family planning method is 
recommended. This position is also in accordance with WHO recommendations, which state that 
insertion of the IUD in an HIV-infected woman or one who is at high risk of infection is not 
usually recommended. However a study in Kenya has raised questions about these guidelines 
(Sinei et al 1998). The study found that there were no more overall complications following 
insertion in HIV-infected women than in uninfected women. The National STI/HIV control 
policy document is however silent on the use of IUDs in HIV-positive patients.  
 
It is also important to examine the impact of the accelerated promotion of the condom in the 
context of STI/HIV/AIDS control on the information provided on other contraceptive methods, 
including the IUD. This is because respondents raised concerns about the cost implications of 
dual protection. Given that the condom is not as effective a contraceptive and a back up is 
essential, there is the need to educate prospective clients on the importance of dual protection.   
 
In promoting the condom, there is the need for education on the proper use of male and female 
condoms. Pairing the two for sale by some chemical shop owners, as mentioned, could give a 
wrong message that the two could be used simultaneously. This practice should be discouraged. 
 
Service Delivery System Barriers 
 
Several barriers at the service delivery level have been identified that may restrict clients access 
to IUD. These include training, cost of the IUD, demand generation/promotion, logistics and 
supplies. 








IUD pre-service training for nurses and midwives appears to be inadequate as it is limited to 
general training and most providers may not have the opportunity to perform any insertions 
because the IUD is a low case load method. Some providers who said that they could not provide 
the service because they had not been adequately trained confirm this assertion. IUD insertion is 
a skill requiring practice, thus even for those trained, a low caseload at the service delivery point 
could result in many losing the skill.  
 
There may be the need to revise the policy requirement that only trained midwives can insert the 
IUD. This requirement blocks nurses who qualify without having done midwifery, and are 
therefore not allowed to perform pelvic examinations. This includes male nurses and nurses 
specialised in public health. Those who had attended family planning training said they had no 
confidence inserting the IUD because they had not been allowed to make any practical insertion 
during the course since they were not midwives.  Ultimately, this limits access to the method. 
 
The information on providers’ experience, which this study tried to obtain based on the number 
of insertions performed was distorted because most of the providers reported on insertions by the 
facility and not about their personal experience. It is important that providers sign for insertions 
that they have personally done. This would be useful in cases of a clinical audit (e.g. evaluation, 
tracing responsibility for complications) and for improving record keeping. What is clear, 
however, is the fact that less than a quarter of providers interviewed had attended the four-week 
comprehensive training for the IUD, which from interviews appears to be the main in-service 
course, and which offers the opportunity to acquire practical insertion skills.  
 
Cost of the IUD 
The average cost of having an IUD inserted in the public facilities was found to be 10,000 Cedis 
(about US$1.22). This amount, when compared to the method’s 10-year lifespan, is cost 
effective. In contrast, the injectable costs about 2000 cedis, but has to be administered four times 
a year, giving a total cost of about 80,000 Cedis for a 10-year period. Thus in real terms the cost 
of the IUD should not be a barrier to use.  However, it is possible that prospective clients may 
find it easier paying 2,000 Cedis upfront than 10,000 Cedis, making the IUD more expensive in 
that instance.  It is also not clear how many couples consider the cost of contraception beyond the 
time of purchase (GSA 1997).  Also, the price range of 30,000 to 200,000 Cedis reported from 
private facilities raises some concern and may be a real barrier to access. 
 
Demand generation and marketing 
The general impression from the discussions is that family planning service agencies have more 
experience in promoting short-term than long-term methods, thus a significant proportion of their 
time is spent providing these methods.  This is worsened by the complexity of service provision 
in the case of the IUD in particular, as well as the unbranded nature of the product.  The advent of 
HIV seems to have aggravated the problem by giving impetus to condom promotion. Even 
agencies such as the Ghana Health Service, who had the original responsibility for promoting the 
IUD, have intensified their efforts in condom promotion. To make the IUD attractive to 






prospective clients, it should be given equal attention. Both public and private sectors should do 
this. Branding the product may also improve marketing and promotion. 
 
Logistics and supplies 
Generally the facilities have adequate logistics and supplies, with only one facility reporting that 
they had not provided the service for a whole year due to shortage. 
 






Conclusions and Recommendations 
 
The stagnating demand for the IUD as a family planning method can be said to be due to several 
factors. The main barriers impeding IUD use are rumours and misconceptions about the method, 
insufficient education about of the product (i.e. poor demand creation), and insufficient number 
of providers with practical experience. 
 
It is important to do more than train providers to insert and remove the IUD; there is the need to 
encourage clients to use it as an option and to encourage providers to provide clear and adequate 








Intensify marketing of the IUD through the Ghana Life Choices Program and other social 
marketing agencies using multiple strategies including branding of the product, and the 
testimonies of satisfied clients to dispel rumours and demystify the product; and 
 
Improve provider confidence in IUD insertion skills through a hands-on training approach 
and create a critical mass of trained IUD providers. 
 
The MOH should review the National Reproductive Health Service Protocols on who qualifies to 
insert and remove the IUD, and also clarify the eligibility criteria with regards to nulliparous and 
HIV-infected clients. The ministry and existing family planning service agencies should also 
address issues related to cost and provide public education on dual protection.  Clients should be 
informed about the ease and cost-effectiveness of using the IUD; that it requires only one visit 
(plus check-up) in contrast to injections or the pill, which require routine visits. 
 
A dissemination meeting held with stakeholders in November 2002 recommended the following 
strategies to improve the marketing and service delivery of the IUD: 
Marketing of the IUD 
Improving product image: It was agreed that experiences from other countries on branding 
should be studied to inform the decision whether to brand or not. Additionally, activities 
should be based on the outcome of the ongoing Life Choices programme for family planning. 
 
Product packaging: It was recommended that the IUD should be pre-packed with other 
expendables such as gloves and gauze. This would help reduce price variations and avoid 
partial stock outs. 
 
Advertising: this should be actively done through the electronic media. Messages on the IUD 
should emphasize the positive attributes of the product and address the identified 
misconceptions. 
 
Target population:  promotional campaigns should also target men since most of the fears or 
rumours that surround the IUD bring out the male concerns. 
 












Personnel: All health cadres with the skill to conduct pelvic exams should be trained to insert 
the IUD.  In-service training should include doctors. 
 
Follow up: Trainers should conduct bi-annual follow-ups. Furthermore, health managers 
should include the IUD in their routine supervision. Follow up activities should include 
capacity assessment as well.  
 
Attrition: Train more providers and encourage managers to maintain trained providers at sites 
where they would be useful. 
 
Refresher training should be regularized and conducted within three to five years after 
training. 
 
Supplies and Equipment 
There is the need to procure more IUD insertion kits for the facilities. Additionally, models 
should be made available at all service delivery points. This will enable providers to practice 
and improve their insertion skills. 
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